| Outgoing Relation(s) |
| antagonist (CHEBI:48706) is a pharmacological role (CHEBI:52210) |
| Incoming Relation(s) |
| carbon dioxide (CHEBI:16526) has role antagonist (CHEBI:48706) |
| GSK2193874 (CHEBI:232516) has role antagonist (CHEBI:48706) |
| PMX-205 (CHEBI:144869) has role antagonist (CHEBI:48706) |
| TNP-ATP (CHEBI:50104) has role antagonist (CHEBI:48706) |
| adenosine receptor antagonist (CHEBI:71232) is a antagonist (CHEBI:48706) |
| AMPA receptor antagonist (CHEBI:71014) is a antagonist (CHEBI:48706) |
| AP-1 antagonist (CHEBI:67199) is a antagonist (CHEBI:48706) |
| aryl hydrocarbon receptor antagonist (CHEBI:76998) is a antagonist (CHEBI:48706) |
| bone morphogenetic protein receptor antagonist (CHEBI:78623) is a antagonist (CHEBI:48706) |
| bradykinin receptor antagonist (CHEBI:68557) is a antagonist (CHEBI:48706) |
| C-X-C chemokine receptor type 4 antagonist (CHEBI:145438) is a antagonist (CHEBI:48706) |
| calcium channel blocker (CHEBI:38215) is a antagonist (CHEBI:48706) |
| calmodulin antagonist (CHEBI:130181) is a antagonist (CHEBI:48706) |
| cannabinoid receptor antagonist (CHEBI:73413) is a antagonist (CHEBI:48706) |
| capsaicin receptor antagonist (CHEBI:70774) is a antagonist (CHEBI:48706) |
| chemokine receptor 2 antagonist (CHEBI:149711) is a antagonist (CHEBI:48706) |
| chemokine receptor 5 antagonist (CHEBI:63673) is a antagonist (CHEBI:48706) |
| CXCR2 antagonist (CHEBI:231732) is a antagonist (CHEBI:48706) |
| dopamine receptor D2 antagonist (CHEBI:131787) is a antagonist (CHEBI:48706) |
| dopaminergic antagonist (CHEBI:48561) is a antagonist (CHEBI:48706) |
| epidermal growth factor receptor antagonist (CHEBI:74440) is a antagonist (CHEBI:48706) |
| estrogen receptor antagonist (CHEBI:50792) is a antagonist (CHEBI:48706) |
| excitatory amino acid antagonist (CHEBI:60798) is a antagonist (CHEBI:48706) |
| fibroblast growth factor receptor antagonist (CHEBI:63457) is a antagonist (CHEBI:48706) |
| G-protein-coupled receptor antagonist (CHEBI:88295) is a antagonist (CHEBI:48706) |
| GABA antagonist (CHEBI:65259) is a antagonist (CHEBI:48706) |
| GABA-gated chloride channel antagonist (CHEBI:38999) is a antagonist (CHEBI:48706) |
| glucocorticoid receptor antagonist (CHEBI:82891) is a antagonist (CHEBI:48706) |
| glutamine antagonist (CHEBI:138931) is a antagonist (CHEBI:48706) |
| glycine receptor antagonist (CHEBI:62754) is a antagonist (CHEBI:48706) |
| histamine antagonist (CHEBI:37956) is a antagonist (CHEBI:48706) |
| hormone antagonist (CHEBI:49020) is a antagonist (CHEBI:48706) |
| IAP antagonist (CHEBI:229692) is a antagonist (CHEBI:48706) |
| insulin-like growth factor receptor 1 antagonist (CHEBI:75252) is a antagonist (CHEBI:48706) |
| IP3 receptor antagonist (CHEBI:131186) is a antagonist (CHEBI:48706) |
| LRH-1 antagonist (CHEBI:136580) is a antagonist (CHEBI:48706) |
| lymphocyte function-associated antigen-1 antagonist (CHEBI:133024) is a antagonist (CHEBI:48706) |
| lysophosphatidic acid receptor antagonist (CHEBI:91193) is a antagonist (CHEBI:48706) |
| melanin-concentrating hormone receptor antagonist (CHEBI:139155) is a antagonist (CHEBI:48706) |
| melatonin receptor antagonist (CHEBI:131790) is a antagonist (CHEBI:48706) |
| metabotropic glutamate receptor antagonist (CHEBI:63963) is a antagonist (CHEBI:48706) |
| neurokinin-1 receptor antagonist (CHEBI:55350) is a antagonist (CHEBI:48706) |
| neurokinin-3 receptor antagonist (CHEBI:140482) is a antagonist (CHEBI:48706) |
| neuropeptide FF receptor antagonist (CHEBI:140982) is a antagonist (CHEBI:48706) |
| neuropeptide Y receptor antagonist (CHEBI:133878) is a antagonist (CHEBI:48706) |
| neuropilin receptor antagonist (CHEBI:166909) is a antagonist (CHEBI:48706) |
| nicotinic acid adenine dinucleotide phosphate receptor antagonist (CHEBI:139180) is a antagonist (CHEBI:48706) |
| odorant receptor antagonist (CHEBI:76531) is a antagonist (CHEBI:48706) |
| opioid receptor antagonist (CHEBI:60605) is a antagonist (CHEBI:48706) |
| orexin receptor antagonist (CHEBI:83296) is a antagonist (CHEBI:48706) |
| platelet glycoprotein-IIb/IIIa receptor antagonist (CHEBI:50433) is a antagonist (CHEBI:48706) |
| platelet-activating factor receptor antagonist (CHEBI:134182) is a antagonist (CHEBI:48706) |
| prostaglandin receptor antagonist (CHEBI:138887) is a antagonist (CHEBI:48706) |
| purinergic receptor P2 antagonist (CHEBI:91079) is a antagonist (CHEBI:48706) |
| retinoic acid receptor antagonist (CHEBI:90714) is a antagonist (CHEBI:48706) |
| saredutant (CHEBI:233291) is a antagonist (CHEBI:48706) |
| SMO receptor antagonist (CHEBI:66908) is a antagonist (CHEBI:48706) |
| sphingosine-1-phosphate receptor antagonist (CHEBI:144987) is a antagonist (CHEBI:48706) |
| substance P receptor antagonist (CHEBI:55351) is a antagonist (CHEBI:48706) |
| TGFβ receptor antagonist (CHEBI:91202) is a antagonist (CHEBI:48706) |
| thromboxane A2 antagonist (CHEBI:85540) is a antagonist (CHEBI:48706) |
| tropomyosin-related kinase B receptor antagonist (CHEBI:78681) is a antagonist (CHEBI:48706) |
| vascular endothelial growth factor receptor antagonist (CHEBI:65207) is a antagonist (CHEBI:48706) |
| vitamin B1 antagonist (CHEBI:78248) is a antagonist (CHEBI:48706) |
| vitamin K antagonist (CHEBI:55347) is a antagonist (CHEBI:48706) |
| α1B-adrenoceptor antagonist (CHEBI:63936) is a antagonist (CHEBI:48706) |
